LICENSE AND COLLABORATION AGREEMENTLicense and Collaboration Agreement • November 9th, 2012 • Enzon Pharmaceuticals Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledNovember 9th, 2012 Company Industry JurisdictionTHIS LICENSE AND COLLABORATION AGREEMENT (the “Agreement”) is entered into this 26th day of July 2006 (the “Effective Date”) by and between Santaris Pharma A/S, a Danish corporation having its principal place of business at Hørsholm, Denmark (“Santaris”), and Enzon Pharmaceuticals, Inc., a Delaware corporation having its principal place of business at Bridgewater, New Jersey 08807 (“Enzon”). Santaris and Enzon may be referred to herein individually as a “Party” or collectively, as the “Parties”.
LICENSE AND COLLABORATION AGREEMENTLicense and Collaboration Agreement • March 9th, 2009 • Enzon Pharmaceuticals Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledMarch 9th, 2009 Company Industry JurisdictionTHIS LICENSE AND COLLABORATION AGREEMENT (the “Agreement”) is entered into this 26th day of July 2006 (the “Effective Date”) by and between Santaris Pharma A/S, a Danish corporation having its principal place of business at Hørsholm, Denmark (“Santaris”), and Enzon Pharmaceuticals, Inc., a Delaware corporation having its principal place of business at Bridgewater, New Jersey 08807 (“Enzon”). Santaris and Enzon may be referred to herein individually as a “Party” or collectively, as the “Parties”.
LICENSE AND COLLABORATION AGREEMENTLicense and Collaboration Agreement • October 21st, 2008 • Evivrus, Inc. • Pharmaceutical preparations • New York
Contract Type FiledOctober 21st, 2008 Company Industry JurisdictionTHIS LICENSE AND COLLABORATION AGREEMENT (the “Agreement”) is entered into this 26th day of July 2006 (the “Effective Date”) by and between Santaris Pharma A/S, a Danish corporation having its principal place of business at Hørsholm, Denmark (“Santaris”), and Enzon Pharmaceuticals, Inc., a Delaware corporation having its principal place of business at Bridgewater, New Jersey 08807 (“Enzon”). Santaris and Enzon may be referred to herein individually as a “Party” or collectively, as the “Parties”.
LICENSE AND COLLABORATION AGREEMENTLicense and Collaboration Agreement • July 31st, 2008 • Evivrus, Inc. • New York
Contract Type FiledJuly 31st, 2008 Company JurisdictionTHIS LICENSE AND COLLABORATION AGREEMENT (the “Agreement”) is entered into this 26th day of July 2006 (the “Effective Date”) by and between Santaris Pharma A/S, a Danish corporation having its principal place of business at Hørsholm, Denmark (“Santaris”), and Enzon Pharmaceuticals, Inc., a Delaware corporation having its principal place of business at Bridgewater, New Jersey 08807 (“Enzon”). Santaris and Enzon may be referred to herein individually as a “Party” or collectively, as the “Parties”.